The company has received 12 Queen's Awards for Technology in its history, most recently in 2006 for low-light imaging devices[4] and in 2004 for thyratrons for cancer radiotherapy treatment.

[citation needed] In its final annual report prior to acquisition, namely for the 12 months ending March 2016, e2v's turnover was £236.4 million, of which 44% was generated from its imaging division, 34% from radiofrequency (RF) power products and 22% from semi-conductors,[5] and it employed around 1,600 staff across nine engineering facilities and six sales offices.

The company has received 13 Queen's Awards for Technology in its history, most recently in 2006[6] for low light imaging devices and in 2004[7] for thyratrons for cancer radiotherapy treatment.

[18] In 2010, the company announced the establishment of the e2v microwave engineering centre in Lincoln,[19] UK as part of a restructuring that saw the move of operational capabilities to the Chelmsford facility.

In 2013 e2v supplied the CCD imaging array for the European Space Agency's (ESA's) Gaia project to map the Milky Way.

In 2015, NASA's New Horizons probe, which had launched from Earth ten years earlier, used CCDs made by e2v to capture images of Pluto.

[22] It is also a supplier of CCDs to ESA for its FLEX satellite, which will study plant health and stress from space and is scheduled for launch into earth orbit in 2024.

e2v also has sales, service and technical support offices in the UK, North America, France, Japan, Korea, and Hong Kong:[citation needed]